K. Baker

发表

NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors.

T. Torgerson, M. Pulsipher, P. Szabolcs, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study.

K. Ness, L. Robison, S. Bhatia, 2005, Archives of pediatrics & adolescent medicine.

National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.

M. Pulsipher, G. McDonald, M. Nieder, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children.

K. Baker, D. Bresters, J. Sande, 2010, Pediatric clinics of North America.

Late Cardiovascular Morbidity and Mortality Following Pediatric Allogeneic Hematopoietic Cell Transplantation

B. Shaw, M. Flowers, Paul L Martin, 2018, Bone Marrow Transplantation.

Signs of Early SubClinical Atherosclerosis in Childhood Cancer Survivors

J. Hodges, J. Steinberger, A. Kelly, 2014 .

Late Effects After Treatment for Leukemia

K. Baker, E. Rajotte, K. Scott Baker, 2012 .

Endothelial Function in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia

K. Ness, S. Glasser, J. Gurney, 2008, Journal of pediatric hematology/oncology.

Body composition, muscle strength deficits and mobility limitations in adult survivors of childhood acute lymphoblastic leukemia

K. Ness, A. Mertens, J. Gurney, 2007, Pediatric blood & cancer.

NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.

C. Gracia, M. Pulsipher, E. Cheng, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita

J. Tolar, S. Savage, B. Alter, 2011, Bone Marrow Transplantation.

Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hem

J. Wagner, J. Tolar, S. Savage, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ethnic differences in chronic health conditions after hematopoietic cell transplantation

S. Bhatia, M. Arora, S. Forman, 2010, Cancer.

Deficits in physical function among young childhood cancer survivors.

J. Steinberger, K. Ness, D. Mulrooney, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation

D. Friedman, B. Mueller, Stephanie J. Lee, 2011, Annals of Internal Medicine.

Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia

D. Friedman, Stephanie J. Lee, C. Roth, 2013, Pediatric blood & cancer.

Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome.

B. Wood, B. Sandmaier, T. Gooley, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Patient-reported outcomes and health status associated with chronic graft-versus-host disease

H. Jim, Stephanie J. Lee, K. Syrjala, 2018, Haematologica.

Health Behaviors and Cancer Screening Practices in Long-term Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

S. Bhatia, D. Weisdorf, S. Forman, 2010, Bone Marrow Transplantation.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms

D. Kleiner, S. Bhatia, E. Engels, 2017 .

Late effects in high‐risk neuroblastoma survivors treated with high‐dose chemotherapy and stem cell rescue

E. Chow, Julie R. Park, Navin Pinto, 2018, Pediatric blood & cancer.

The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation (HCT): Defining the Unique Late Effects of Children undergoing HCT for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemogl

P. Rosenberg, J Wagner, L. Notarangelo, 2017 .

NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.

J. Kurtzberg, S. Bhatia, M. Pulsipher, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blunted response to a growth hormone stimulation test is associated with unfavorable cardiovascular risk factor profile in childhood cancer survivors

J. Steinberger, B. Frohnert, A. Sinaiko, 2013, Pediatric blood & cancer.

Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

L. Robison, T. Kawashima, W. Leisenring, 2010, Blood.

Bone mineral deficits in recipients of hematopoietic cell transplantation: the impact of young age at transplant

J. Hodges, J. Steinberger, D. Dengel, 2013, Bone Marrow Transplantation.

Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation

M. Steiner, E. Gulbahce, C. Peters, 2000, Bone Marrow Transplantation.

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation.

H. Deeg, R. Storb, B. Sandmaier, 2019, Blood.

Late Effects in Survivors of Acute Leukemia Treated with Hematopoietic Cell Transplantation: a Report from the Bone Marrow Transplant Survivor Study

K. Ness, S. Bhatia, D. Weisdorf, 2010, Leukemia.

Vascular Structure and Function in Cancer Survivors after Hematopoietic Stem Cell Transplantation.

J. Hodges, J. Steinberger, A. Kelly, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adipokines, Inflammation, and Adiposity in Hematopoietic Cell Transplantation Survivors.

J. Steinberger, W. Leisenring, E. Chow, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation.

D. Mulrooney, M. Arora, A. Blaes, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study

J. Lai, M. MacMillan, K. Baird, 2014, Supportive Care in Cancer.

Vitamin D status among long-term survivors of hematopoietic cell transplantation

D. Mulrooney, K. Robien, D. Lazovich, 2010, Bone Marrow Transplantation.

Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate‐dose of rabbit anti‐thymocyte globulin

M. Rhodes, S. Soni, T. Gross, 2014, Pediatric blood & cancer.

Cancer survivorship care for young adults: a risk-stratified, multicenter randomized controlled trial to improve symptoms

S. Palmer, P. Ganz, W. Leisenring, 2021, Journal of Cancer Survivorship.

NCI, NHLBI First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Long Term Organ Damage and Dysfunction Following Pediatric Hematopoietic Cell Transplantation

G. McDonald, M. Nieder, S. Armenian, 2011 .

Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.

S. Pai, C. Bollard, M. Pulsipher, 2018, Blood.

Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.

S. Schwartz, W. Leisenring, M. Boeckh, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths

M. Roncarolo, B. Blazar, K. Baker, 1999, Bone Marrow Transplantation.

Growth and Development After Hematopoietic Cell Transplantation

A. Petryk, K. Baker, 2016 .

Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.

J. Wagner, J. Tolar, S. Savage, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Fail

P. Rosenberg, J. Wagner, L. Notarangelo, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Role of Follicle-stimulating Hormone in Vascular Dysfunction Observed in Hematopoietic Cell Transplant Recipients

J. Hodges, J. Steinberger, D. Dengel, 2020, Journal of pediatric hematology/oncology.

Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation.

J. Wagner, J. Steinberger, M. MacMillan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long‐term voriconazole

S. Meshinchi, J. Englund, K. Baker, 2015, Pediatric blood & cancer.

Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources

Julie R. Park, K. Baker, P. Carpenter, 2018, Journal of global oncology.

Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning

A. Fischer, E. Lanino, R. Krance, 2015, British journal of haematology.

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia

S. Tarima, O. Ringdén, P. McCarthy, 2011, Bone Marrow Transplantation.

Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipients

B. Sandmaier, Stephanie J. Lee, T. Gooley, 2022, Bone Marrow Transplantation.

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

D. Kaufman, J. Wagner, K. Dusenbery, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents.

W. Wood, M. Sorror, H. Lazarus, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for MDS and AML evolving from MDS

H. Deeg, B. Sandmaier, T. Gooley, 2016 .

HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Non-Malignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide.

T. Torgerson, R. Storb, B. Sandmaier, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chemotherapy-Only Preparative Regimen for Alternative Donor Hematopoietic Cell Transplantation for Patients with Fanconi Anemia (FA): Results of a Multi-Institutional Study

David A. Williams, E. Guinan, K. Myers, 2015 .

Marshall-Stickler phenotype associated with von Willebrand disease.

G. B. Schaefer, K. Baker, G. Schaefer, 1997, American journal of medical genetics.

Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.

T. Torgerson, R. Storb, B. Storer, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

A. King, M. Pulsipher, E. Angelucci, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the bone marrow transplant survivor study

L. Robison, S. Bhatia, J. Gurney, 2006, Bone Marrow Transplantation.

Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.

D. Mulrooney, L. Meacham, S. Bhatia, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.

J. Kurtzberg, S. Bhatia, C. Gracia, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors.

W. Leisenring, Stephanie J. Lee, K. Syrjala, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.

B. Storer, J. Sanders, K. Baker, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach

F. M. Stewart, B. Sandmaier, F. Appelbaum, 2020, Bone Marrow Transplantation.

Transplant outcomes for primary immunodeficiency disease.

T. Gross, K. Baker, Angela R. Smith, 2010, Seminars in hematology.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

A. Barrett, D. Kleiner, S. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation for metabolic storage diseases

J. Tolar, P. Orchard, K. Baker, 2010 .

Late Effects in Survivors After Hematopoietic Cell Transplantation in Childhood

A. Petryk, K. Baker, P. Carpenter, 2014 .

Impact of radiation and chemotherapy on risk of dental abnormalities

M. Hudson, L. Robison, M. Yeazel, 2009, Cancer.

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

M. Norkin, W. Wood, J. Wingard, 2015, Bone Marrow Transplantation.

Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects afte

L. Notarangelo, J. Puck, A. Gennery, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia

W. Woods, B. Bostrom, B. Blazar, 2000, Bone Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.

R. Storb, B. Sandmaier, A. Geddis, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).

M. Hudson, L. Robison, T. Kawashima, 2011, Blood.

Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation.

M. Steinbuch, R. Shapiro, A. Filipovich, 1997, Blood.

Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.

David A. Williams, E. Guinan, K. Myers, 2017, Blood.

Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children

B. Hadland, W. Leisenring, S. Meshinchi, 2019, Bone Marrow Transplantation.

Risk Factors for Development of Pneumatosis Intestinalis After Pediatric Hematopoietic Stem Cell Transplantation: A Single-Center Case-Control Study.

T. Gooley, H. Zheng, A. Gray, 2022, Transplantation and cellular therapy.

Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group

W. Leisenring, L. Constine, S. Lipshultz, 2021, Cancer.

Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.

W. Leisenring, L. Constine, S. Lipshultz, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.

J. Klein, D. Friedman, K. Ballen, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Cell Transplantation and Novel Therapies in Hemophagocytic Lymphohistiocytosis

M. Jordan, K. Baker, 2018 .

Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).

S. Bhatia, D. Weisdorf, S. Forman, 2011, Blood.

Variation in Prescribing Patterns and Therapeutic Drug Monitoring of Intravenous Busulfan in Pediatric Hematopoietic Cell Transplant Recipients

J. Barrett, D. Blough, J. McCune, 2013, Journal of clinical pharmacology.

Transplant Survivor Study functional status of long-term survivors: report from the Bone Marrow Late mortality after allogeneic hematopoietic cell transplantation and

A. Nademanee, L. Robison, S. Bhatia, 2011 .

Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors

Purushottam W. Laud, J. Wingard, K. Syrjala, 2018, Haematologica.

Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.

S. Bhatia, D. Weisdorf, J. Kersey, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Kinetic and organ-specific patterns of cytokine expression in acute graft-versus-host disease.

K. Baker, C. Sidman, J. Roths, 1995, Bone marrow transplantation.

Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation.

W. Leisenring, Stephanie J. Lee, K. Syrjala, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Comparison of Hematopoietic Cell Transplant Conditioning Regimens for Hemophagocytic Lymphohistiocytosis Disorders.

Michael J. Eckrich, A. Gennery, T. Olson, 2021, The Journal of allergy and clinical immunology.

Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Ped

L. Notarangelo, J. Puck, A. Gennery, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada.

J. Klein, M. Horowitz, Stephanie J. Lee, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term consequences of hematopoietic stem cell transplantation: current state of the science.

S. Bhatia, S. Armenian, K. Baker, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant

J. Wagner, J. Tolar, M. MacMillan, 2011, Bone Marrow Transplantation.

NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes.

K. Ness, S. Phipps, M. Pulsipher, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Subsequent malignant neoplasms after hematopoietic cell transplantation.

S. Bhatia, G. Socié, K. Baker, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quality of life and recovery after graft-versus-host disease.

K. Baker, C. Fraser, 2008, Best practice & research. Clinical haematology.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

M. Norkin, W. Wood, J. Snowden, 2016, Bone Marrow Transplantation.

Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.

D. Mulrooney, N. Majhail, K. Baker, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New M alignancies A fter B lood o r M arrow S tem-Cell Transplantation i n C hildren a nd A dults: Incidence a nd R isk F actors

L. Robison, J. Neglia, T. DeFor, 2003 .

Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow‐up

B. Storer, K. Baker, S. Hingorani, 2014, Pediatric blood & cancer.

Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.

J. Wingard, K. Syrjala, N. Majhail, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation

W. Leisenring, Stephanie J. Lee, K. Syrjala, 2017, Cancer.

Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation

J. Steinberger, E. Chow, K. Baker, 2012, Bone Marrow Transplantation.

Late cardiovascular complications after hematopoietic cell transplantation.

W. Leisenring, D. Friedman, B. Mueller, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Engaging hematopoietic cell transplantation patients and caregivers in the design of print and mobile application individualized survivorship care plan tools

K. Syrjala, Jean C. Yi, N. Majhail, 2019, Supportive Care in Cancer.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Hamadani, M. Norkin, W. Wood, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

W. Wood, H. Jim, J. Wingard, 2022, Transplantation and cellular therapy.

Population-Based Analysis of Late Cardiovascular Morbidity and Hospitalizations After Hematopoietic Cell Transplantation.

D. Friedman, B. Mueller, Stephanie J. Lee, 2009 .

Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.

M. Aljurf, L. Diller, R. Gale, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

PROMIS measures can be used to assess symptoms and function in long‐term hematopoietic cell transplantation survivors

D. Fairclough, H. Jim, M. Horowitz, 2018, Cancer.

Changes in biomarkers of bone resorption over the first six months after pediatric hematopoietic cell transplantation

K. Rudser, A. Petryk, K. Baker, 2012, Pediatric transplantation.

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.

M. Krem, Stephanie J. Lee, K. Syrjala, 2021, Transplantation and cellular therapy.

Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation.

L. Robison, T. Bergemann, A. Petryk, 2005, The Journal of clinical endocrinology and metabolism.

Prediction of Busulfan Clearance by Predose Plasma Metabolomic Profiling

Brian R. Phillips, H. Deeg, A. Huitema, 2022, Clinical pharmacology and therapeutics.

Prediction of Acute Graft versus Host Disease and Relapse by Endogenous Metabolomic Compounds in Patients Receiving Personalized Busulfan-Based Conditioning.

H. Deeg, A. Huitema, E. V. van Maarseveen, 2020, Journal of proteome research.

Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.

D. Friedman, C. Roth, J. Simmons, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Feasibility and acceptability of a home‐based resistance training intervention in adolescent and young adult hematopoietic cell transplant survivors

M. Bradford, A. Rosenberg, E. Chow, 2021, Pediatric blood & cancer.

Physical Activity, Fitness, and Cardiometabolic Risk Factors in Adult Survivors of Childhood Cancer with a History of Hematopoietic Cell Transplantation.

J. Steinberger, A. Sinaiko, L. Chow, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cardiovascular risk and insulin resistance in childhood cancer survivors.

J. Steinberger, A. Sinaiko, D. Mulrooney, 2012, The Journal of pediatrics.

Feasibility of delivering survivorship care via lay health educators: A pilot randomized controlled trial among rural cancer survivors.

A. Cole, E. Chow, C. Duggan, 2023, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

Cardiometabolic risk in childhood cancer survivors: a report from the Children's Oncology Group.

L. Constine, S. Lipshultz, S. Bhatia, 2021, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Modifiable risk factors associated with bone deficits in childhood cancer survivors

J. Steinberger, A. Sinaiko, W. Leisenring, 2012, BMC Pediatrics.

Health knowledge about symptoms of heart attack and stroke in adult survivors of childhood acute lymphoblastic leukemia.

K. Ness, S. Glasser, J. Gurney, 2007, Annals of epidemiology.

Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.

J. Kurtzberg, P. Veys, O. Ringdén, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Signs of early sub‐clinical atherosclerosis in childhood cancer survivors

J. Steinberger, A. Kelly, D. Dengel, 2014, Pediatric blood & cancer.

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.

W. Wood, H. Jim, J. Wingard, 2023, Transplantation and cellular therapy.

Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer

S. Colan, W. Leisenring, L. Constine, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Socioeconomic Factors and Adherence to Health Care Recommendations in Adolescent and Young Adult Cancer Survivors.

S. Palmer, P. Ganz, A. Partridge, 2023, Journal of Adolescent and Young Adult Oncology.

Late mortality and relapse after dexrazoxane (DRZ) treatment: An update from the Children’s Oncology Group (COG).

W. Leisenring, L. Constine, S. Lipshultz, 2014 .

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

J. Klein, K. Ballen, Stephanie J. Lee, 2007 .

NCCN Guidelines® Insights: Survivorship, Version 1.2022.

Deborah A. Freedman-Cass, W. Demark-Wahnefried, M. Hudson, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG)

W. Leisenring, L. Constine, S. Lipshultz, 2016 .

Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.

K. Ness, S. Bhatia, J. Gurney, 2005, Blood.

Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.

Catherine J. Wu, J. Wagner, Wandi Zhang, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ethnic Differences in the Prevalence of, and Predictors for Anxiety, Depression, and Somatic Distress in Long-Term Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

S. Bhatia, S. Forman, K. Baker, 2008 .

Adolescent and Young Adult Cancer Survivors: Late Effects of Treatment

P. Nathan, M. Hawkins, K. Baker, 2017 .

Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study.

K. Ness, L. Robison, S. Bhatia, 2004, Blood.

Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation

J. Steinberger, K. Baker, E. Chow, 2012 .

Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.

D. Mulrooney, L. Meacham, S. Bhatia, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-Term Outcomes In Survivors of Childhood Cancer Treated with Hematopoietic Cell Transplantation (HCT) Versus Conventional Therapy: a Report From the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

M. Hudson, L. Robison, T. Kawashima, 2010 .

J. Wagner, J. Tolar, S. Savage, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Idiopathic Pneumonitis Syndrome After Total Body Irradiation in Pediatric Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation: A PENTEC Comprehensive Review.

L. Constine, K. Dusenbery, Shiva K. Das, 2023, International journal of radiation oncology, biology, physics.

Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).

S. Bhatia, D. Weisdorf, S. Forman, 2011, Blood.

Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders.

D. Cornfield, I. Y. Haddad, B. Blazar, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.